2007
DOI: 10.1007/s00428-007-0418-3
|View full text |Cite
|
Sign up to set email alerts
|

Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies

Abstract: We performed a retrospective analysis on kidney biopsies of 30 human immunodeficiency virus (HIV)-positive patients. Twenty-two of them received highly active antiretroviral therapy (HAART). Tenofovir containing HAART together with atazanavir, a new protease inhibitor, was administered to three patients. All of them developed acute renal failure. The kidney biopsies of these patients showed an acute interstitial nephritis or a chronic interstitial nephritis with an acute component. Withdrawal of atazanavir and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
36
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(37 citation statements)
references
References 18 publications
1
36
0
Order By: Relevance
“…Previous case reports reported TDF-associated renal toxicity, including acute tubular necrosis [6], Fanconi syndrome [7-9], and ultimately, renal failure [10] characterized by a decline in glomerular filtration rates (GFRs) and hypophosphatemia [11,12]. Studies with primarily Caucasian patients report low rates of tenofovir-associated nephrotoxicity, and severe renal impairment is rare in clinical trials of tenofovir-containing first line antiretroviral therapy (ART) regimens [13,14].…”
Section: Introductionmentioning
confidence: 99%
“…Previous case reports reported TDF-associated renal toxicity, including acute tubular necrosis [6], Fanconi syndrome [7-9], and ultimately, renal failure [10] characterized by a decline in glomerular filtration rates (GFRs) and hypophosphatemia [11,12]. Studies with primarily Caucasian patients report low rates of tenofovir-associated nephrotoxicity, and severe renal impairment is rare in clinical trials of tenofovir-containing first line antiretroviral therapy (ART) regimens [13,14].…”
Section: Introductionmentioning
confidence: 99%
“…Tenofovir was highly likely the causative drug, because sulfamethoxazole/trimethoprim, the other drug which was used just before the occurrence of AIN, had been intermittently used for more than two months before the introduction of ART without any complications. To our knowledge, this is the fourth reported case of tenofovir-induced AIN, in addition to the three cases reported by Schmid et al (6). Nevertheless, it is difficult to entirely role out the involvement of sulfamethoxazole/trimethoprim in occurrence of this AIN case.…”
Section: Discussionmentioning
confidence: 64%
“…Therefore, there was a possibility that the TDF nephrotoxity was enhanced by the use of Ritonavir in the current patient. A recent study has evaluated the renal injuries in kidney biopsies of 30 HIV patients undergoing ATV therapy (23). TIN was found in six patients and the combination of ATV and TDF was noted in three of them.…”
Section: Discussionmentioning
confidence: 99%